Similarly, RANK-expressing breast and prostate cancer cell lines demonstrate upregulation of matrix metalloproteinase-1 (MMP-1) and subsequent migration and invasion upon RANKL administration (59). This evidence concerns the gene TNFRSF11A and prostate carcinoma.